STOPP criteria

STOPP (Screening Tool of Older People's Prescriptions) criteria are a systematic, evidence-based tool developed by European geriatric experts to identify Potentially Inappropriate Medications (PIMs) in adults aged 65 and older. The criteria list specific drug-related situations that should be avoided or used with caution. In risk management, applying STOPP criteria intersects clinical and information governance. The prescription data processed is considered sensitive health data under regulations like GDPR Article 9 and Taiwan's PDPA Article 6. Therefore, any system using these criteria must operate within a Privacy Information Management System (PIMS) framework compliant with ISO/IEC 27701 to ensure lawful, secure, and purpose-limited data processing, mitigating both clinical and data breach risks.

In enterprise risk management, especially within healthcare organizations, STOPP criteria are primarily implemented through a Clinical Decision Support System (CDSS) to systematically reduce medication-related risks. Key implementation steps include: 1. **Data Governance and Integration**: Establish an ISO/IEC 27701-compliant PIMS to integrate disparate Electronic Health Records (EHR) and medication data into a secure platform with strict access controls. 2. **Rule Engine Implementation**: Program the STOPP criteria into the CDSS. The system automatically screens prescriptions in real-time against a patient's profile, flagging potential issues for review. 3. **Monitoring and Improvement**: Regularly generate reports on PIM rates and alert acceptance rates. A medical center that implemented this saw a 15% reduction in PIMs in the first year, enhancing patient safety and passing regulatory audits on medication safety.

Taiwanese healthcare organizations face three main challenges when implementing STOPP criteria: 1. **Data Silos and Interoperability**: Patient data is often fragmented across different systems, hindering comprehensive screening. The solution is to adopt standards like HL7 FHIR to create a unified data platform under a robust PIMS framework. 2. **Localization of Clinical Criteria**: The original European criteria may not fully align with local formularies and practices. The solution is to form a multidisciplinary team to review and adapt the criteria, documenting all changes for compliance. 3. **User Resistance and Alert Fatigue**: Clinicians may ignore frequent alerts. The solution is to design a tiered alert system (e.g., critical vs. informational), provide a feedback mechanism to refine rules, and implement a phased rollout starting with high-risk medications to ensure user buy-in.

Winners Consulting specializes in STOPP criteria for Taiwan enterprises, delivering compliant management systems within 90 days. Free consultation: https://winners.com.tw/contact